Trials / Completed
CompletedNCT05318131
Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary objectives of this study are to examine sleep, exercise, and nutrition in prostate cancer.
Detailed description
The primary objective of this study is to determine whether exposure to a website with recommendations about sleep and lifestyle for patients with prostate cancer and caregivers leads to an improvement in sleep and healthy lifestyle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sleep and Lifestyle Advice Website | Participants will be asked to view a website at least once a week for 3 months (remotely). The website includes information about exercise, nutrition and sleep. Participants will also have a check-in call with a health coach at 6 weeks, and will be sent email newsletters at approximately 1 and 2 months with additional information about sleep, nutrition, and exercise. |
| OTHER | Surveys and Sleep Monitors | At baseline and at 3 months, participants will be asked to complete online surveys and to wear an ActiGraph sleep monitor for one week. ActiGraph sleep monitors are wristbands that measure continuous sleep/wake activity information. The recorded ActiGraph data is deidentified and no individual personally identifiable information is collected. A unique serial number identifies each wrist monitor. At the end of the study, participants will also have a telephone exit interview with the study team to provide feedback on their progress during the study and about the website. |
Timeline
- Start date
- 2022-08-30
- Primary completion
- 2023-09-26
- Completion
- 2023-10-12
- First posted
- 2022-04-08
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05318131. Inclusion in this directory is not an endorsement.